165 related articles for article (PubMed ID: 7791265)
21. A decision tree for differentiating tuberculous from malignant pleural effusions.
Porcel JM; Alemán C; Bielsa S; Sarrapio J; Fernández de Sevilla T; Esquerda A
Respir Med; 2008 Aug; 102(8):1159-64. PubMed ID: 18573650
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions.
Okamoto M; Kawabe T; Iwasaki Y; Hara T; Hashimoto N; Imaizumi K; Hasegawa Y; Shimokata K
J Lab Clin Med; 2005 Feb; 145(2):88-93. PubMed ID: 15746651
[TBL] [Abstract][Full Text] [Related]
23. Role of biochemical tests in the diagnosis of exudative pleural effusions.
Ernam D; Atalay F; Hasanoglu HC; Kaplan O
Clin Biochem; 2005 Jan; 38(1):19-23. PubMed ID: 15607312
[TBL] [Abstract][Full Text] [Related]
24. Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis.
Kabut J; Kondera-Anasz Z; Sikora J; Mielczarek-Palacz A
Fertil Steril; 2007 Nov; 88(5):1298-303. PubMed ID: 17482181
[TBL] [Abstract][Full Text] [Related]
25. Elevated soluble CD26 levels in patients with tuberculous pleurisy.
Oshikawa K; Sugiyama Y
Int J Tuberc Lung Dis; 2001 Sep; 5(9):868-72. PubMed ID: 11573900
[TBL] [Abstract][Full Text] [Related]
26. Role of pleural viscosity in the differential diagnosis of exudative pleural effusion.
Yetkin O; Tek I; Yetkin F; Numanoglu N
Respirology; 2007 Mar; 12(2):267-71. PubMed ID: 17298461
[TBL] [Abstract][Full Text] [Related]
27. [Detection of D -dimer in pleural effusion].
Lü YD; Chen P; Xu M
Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):71-2. PubMed ID: 12212257
[TBL] [Abstract][Full Text] [Related]
28. Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion.
Elsammak M MY; Morsi TS; Khamis HI; Ragab MS; Zaki MA; Abdel-Hadi M; Hassan HA
Ann Clin Biochem; 2007 May; 44(Pt 3):264-72. PubMed ID: 17456294
[TBL] [Abstract][Full Text] [Related]
29. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
[TBL] [Abstract][Full Text] [Related]
30. Pleural SC5b-9: a test for identifying complicated parapneumonic effusions.
Vives M; Porcel JM; Gázquez I; Pérez B; Rubio M
Respiration; 2000; 67(4):433-8. PubMed ID: 10940799
[TBL] [Abstract][Full Text] [Related]
31. [Activation of the alternative complement pathway in pleural fluid of patients with pneumonia].
Aguado MT; Celada A
Allergol Immunopathol (Madr); 1982; 10(3):215-20. PubMed ID: 6924537
[TBL] [Abstract][Full Text] [Related]
32. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.
Chang SC; Hsu YT; Chen YC; Lin CY
Arch Intern Med; 1994 May; 154(10):1097-101. PubMed ID: 8185423
[TBL] [Abstract][Full Text] [Related]
34. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
[TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
Ni SS; Gao ZL
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
[TBL] [Abstract][Full Text] [Related]
36. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
37. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients.
Vallhonrat H; Williams WW; Cosimi AB; Tolkoff-Rubin N; Ginns LC; Wain JC; Preffer F; Olszak I; Wee S; Delmonico FL; Pascual M
Transplantation; 1999 Jan; 67(2):253-8. PubMed ID: 10075589
[TBL] [Abstract][Full Text] [Related]
38. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of ferritin, haptoglobin, alpha 1-antitrypsin, lactate dehydrogenase and complement factors C3 and C4 in pleural effusion differentiation.
Alexandrakis M; Coulocheri S; Kyriakou D; Bouros D; Xirouhaki N; Siafakas N; Castanas E; Eliopoulos GD
Respir Med; 1997 Oct; 91(9):517-23. PubMed ID: 9415351
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
Podack ER; Preissner KT; Müller-Eberhard HJ
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
